How have ELVN and IRTC total returns compared?

Over the past 5 years, ELVN delivered 24.57% and IRTC delivered 12.95% annualized total return. Past performance doesn't predict future results.

Enliven Therapeutics, Inc. (ELVN) vs iRhythm Technologies, Inc. (IRTC)

A side-by-side comparison of Enliven Therapeutics, Inc. and iRhythm Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELVN

Enliven Therapeutics, Inc.

$2.97B

$41.61HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

IRTC

iRhythm Technologies, Inc.

$3.52B

$107.02HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

Total return — ELVN vs IRTC

growth of $100 · dividends reinvested · last 7y

ELVN -24.2% (-3.9%/yr)IRTC +41.2% (+5.1%/yr)IRTC compounded faster over this window

ELVN IRTC

ELVN vs IRTC: by the numbers

•IRTC is the larger company ($3.52B vs $2.97B market cap).
•Both run net losses; ELVN's is the smaller (0.00% vs -1.69% net margin).

Metrics side by side

Valuation

Metric	ELVN	IRTC
P/S ratio	N/A	4.26
P/B ratio	3.32	18.91
EV / EBITDA	N/A	285.93
FCF yield	N/A	1.11%

Profitability

Metric	ELVN	IRTC
Gross margin	0.00%	71.45%
Operating margin	0.00%	-1.17%
Net margin	0.00%	-1.69%
ROE	-11.83%	-7.50%
ROIC	-13.88%	-1.07%

Growth (annualized)

Metric	ELVN	IRTC
Revenue CAGR (5Y)	N/A	21.93%
Total return CAGR (5Y)	24.57%	12.95%

Frequently asked

How have ELVN and IRTC total returns compared?: Over the past 5 years, ELVN delivered 24.57% and IRTC delivered 12.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELVN analysis Full IRTC analysis Interactive comparison tool

Dig into the metrics

Enliven Therapeutics ROE iRhythm Technologies ROE Enliven Therapeutics operating margin iRhythm Technologies operating margin Enliven Therapeutics revenue growth iRhythm Technologies revenue growth Enliven Therapeutics free cash flow iRhythm Technologies free cash flow

Enliven Therapeutics & iRhythm Technologies appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.